C8β activators are a class of chemical compounds that are characterized by their ability to modulate the activity of specific proteins within the family of C8-containing proteins, where the "β" denotes their interaction with a particular protein subunit. These proteins are part of a broader set of molecules that play roles in various cellular processes, including but not limited to metabolic pathways, signal transduction, and the maintenance of cellular structures. C8β activators achieve their function by binding to the C8β subunit, thereby inducing a conformational change, which can result in the alteration of the protein's activity. This modulation can either enhance or inhibit the function of the target protein, depending on the nature of the activator and the context of its action within the cell.
The chemistry surrounding C8β activators is rich with diversity, as these molecules can be found in or inspired by a myriad of structural backbones, ranging from simple organic compounds to complex natural products. The chemical properties of C8β activators are fine-tuned to allow for selective interaction with the C8β subunit, a feature that often requires a high degree of specificity in the molecular design. This specificity is typically achieved through the presence of functional groups that can form non-covalent interactions such as hydrogen bonds, hydrophobic interactions, and Van der Waals forces with the target protein. The precise arrangement of these functional groups is crucial, as it determines the affinity and efficacy of the activator.
| Product Name | CAS # | Catalog # | QUANTITY | Price | Citations | RATING |
|---|---|---|---|---|---|---|
Zymosan | 9010-72-4 | sc-296863 sc-296863A | 100 mg 1 g | $99.00 $599.00 | 1 | |
Derived from yeast, Zymosan activates the complement system via the alternative pathway, potentially increasing C8β activity. | ||||||
C5a Receptor Antagonist, W-54011 | 405098-33-1 | sc-203863 sc-203863A | 1 mg 5 mg | $206.00 $645.00 | 7 | |
An anaphylatoxin that can amplify complement activation, potentially leading to upregulated C8β levels and function. | ||||||
PMA | 16561-29-8 | sc-3576 sc-3576A sc-3576B sc-3576C sc-3576D | 1 mg 5 mg 10 mg 25 mg 100 mg | $41.00 $132.00 $214.00 $500.00 $948.00 | 119 | |
Protein kinase C (PKC) activator. Activation of PKC could influence the expression or stabilization of C8β. | ||||||
Ionomycin, free acid | 56092-81-0 | sc-263405 sc-263405A | 1 mg 5 mg | $96.00 $264.00 | 2 | |
Elevates intracellular calcium levels which may promote activation of pathways influencing C8β function. | ||||||
Dibutyryl-cAMP | 16980-89-5 | sc-201567 sc-201567A sc-201567B sc-201567C | 20 mg 100 mg 500 mg 10 g | $47.00 $136.00 $492.00 $4552.00 | 74 | |
Analog of cAMP that activates PKA, potentially influencing pathways that may upregulate or stimulate C8β activity. | ||||||
Concanavalin A | 11028-71-0 | sc-203007 sc-203007A sc-203007B | 50 mg 250 mg 1 g | $119.00 $364.00 $947.00 | 17 | |
Can activate the lectin pathway of the complement system, thereby potentially influencing C8β activity. | ||||||
Lipopolysaccharide, E. coli O55:B5 | 93572-42-0 | sc-221855 sc-221855A sc-221855B sc-221855C | 10 mg 25 mg 100 mg 500 mg | $98.00 $171.00 $425.00 $1560.00 | 12 | |
Component of bacterial cell walls, can activate the complement system, potentially increasing C8β activity. | ||||||
C3A Receptor Agonist | 944997-60-8 | sc-214644 sc-214644A | 1 mg 5 mg | $169.00 $668.00 | 1 | |
Like C5a, C3a can amplify complement activation, potentially leading to an increased activity of C8β. | ||||||